GPCR-like signaling mediated by smoothened contributes to acquired chemoresistance through activating Gli

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Zhan, Xia ^a   Wang, Juan ^a   Liu, Yuan ^a   Peng, Yuanqiu ^a   Tan, Wenfu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Acquired chemoresistance; Gli; GPCR; JNK; Smoothened

Indexed keywords

DOXORUBICIN; ETOPOSIDE; G PROTEIN COUPLED RECEPTOR; IMATINIB; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1; VINCRISTINE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL STRAIN HEK293; CHRONIC MYELOID LEUKEMIA; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NONHUMAN; PLASMID; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

ERINACEIDAE;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASMS; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84892171530     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-4     Document Type: Article

References (60)

1. Ingham PW, McMahon AP. Hedgehog signaling in animal development: paradigms and principles. Genes Dev 2001, 15:3059-3087. 10.1101/gad.938601, 11731473.
2. Varjosalo M, Taipale J. Hedgehog: functions and mechanisms. Genes Dev 2008, 22:2454-2472. 10.1101/gad.1693608, 18794343.
3. Scales SJ, de Sauvage FJ. Mechanisms of hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol Sci 2009, 30:303-312. 10.1016/j.tips.2009.03.007, 19443052.
4. Guha M. Hedgehog inhibitor gets landmark skin cancer approval, but questions remain for wider potential. Nat Rev Drug Discov 2012, 11:257-258. 10.1038/nrd3714, 22460111.
5. Hammerschmidt M, McMahon AP. The effect of pertussis toxin on zebrafish development: a possible role for inhibitory G-proteins in hedgehog signaling. Dev Biol 1998, 194:166-171. 10.1006/dbio.1997.8796, 9501021.
6. DeCamp DL, Thompson TM, de Sauvage FJ, Lerner MR. Smoothened activates Galphai-mediated signaling in frog melanophores. J Biol Chem 2000, 275:26322-26327. 10.1074/jbc.M004055200, 10835429.
7. Wang C, Wu H, Katritch V, Han GW, Huang XP, Liu W, Siu FY, Roth BL, Cherezov V, Stevens RC. Structure of the human smoothened receptor bound to an antitumour agent. Nature 2013, 497:338-343. 10.1038/nature12167, 23636324.
8. Ogden SK, Fei DL, Schilling NS, Ahmed YF, Hwa J, Robbins DJ. G protein galphai functions immediately downstream of smoothened in hedgehog signalling. Nature 2008, 456:967-970. 10.1038/nature07459, 2744466, 18987629.
9. Riobo NA, Saucy B, Dilizio C, Manning DR. Activation of heterotrimeric G proteins by smoothened. Proc Natl Acad Sci USA 2006, 103:12607-12612. 10.1073/pnas.0600880103, 1567926, 16885213.
10. Low WC, Wang C, Pan Y, Huang XY, Chen JK, Wang B. The decoupling of smoothened from galphai proteins has little effect on Gli3 protein processing and hedgehog-regulated chick neural tube patterning. Dev Biol 2008, 321:188-196. 10.1016/j.ydbio.2008.06.014, 2597282, 18590719.
11. Polizio AH, Chinchilla P, Chen X, Kim S, Manning DR, Riobo NA. Heterotrimeric Gi proteins link hedgehog signaling to activation of Rho small GTPases to promote fibroblast migration. J Biol Chem 2011, 286:19589-19596. 10.1074/jbc.M110.197111, 3103338, 21474452.
12. Chinchilla P, Xiao L, Kazanietz MG, Riobo NA. Hedgehog proteins activate pro-angiogenic responses in endothelial cells through non-canonical signaling pathways. Cell Cycle 2010, 9:570-579. 10.4161/cc.9.3.10591, 20081366.
13. Belgacem YH, Borodinsky LN. Sonic hedgehog signaling is decoded by calcium spike activity in the developing spinal cord. Proc Natl Acad Sci USA 2011, 108:4482-4487. 10.1073/pnas.1018217108, 3060219, 21368195.
14. Qu C, Liu Y, Kunkalla K, Singh RR, Blonska M, Lin X, Agarwal NK, Vega F. Trimeric G protein-CARMA1 axis links smoothened, the hedgehog receptor transducer, to NF-kappaB activation in diffuse large B-cell lymphoma. Blood 2013, 121:4718-4728. 10.1182/blood-2012-12-470153, 23632891.
15. Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 2002, 3:639-650. 10.1038/nrm908, 12209124.
16. Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, Castillo-Martin M, Quinn SA, Rodriguez-Barrueco R, Bonal DM, Charytonowicz E, Gladoun N, de la Iglesia-Vicente J, et al. Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells. Cancer Cell 2012, 22:373-388. 10.1016/j.ccr.2012.07.016, 22975379.
17. Sims-Mourtada J, Izzo JG, Ajani J, Chao KS. Sonic hedgehog promotes multiple drug resistance by regulation of drug transport. Oncogene 2007, 26:5674-5679. 10.1038/sj.onc.1210356, 17353904.
18. Zhang Y, Laterra J, Pomper MG. Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp. Neoplasia 2009, 11:96-101. 2606123, 19107236.
19. Queiroz KC, Ruela-de-Sousa RR, Fuhler GM, Aberson HL, Ferreira CV, Peppelenbosch MP, Spek CA. Hedgehog signaling maintains chemoresistance in myeloid leukemic cells. Oncogene 2010, 29:6314-6322. 10.1038/onc.2010.375, 20802532.
20. Singh RR, Kunkalla K, Qu C, Schlette E, Neelapu SS, Samaniego F, Vega F. ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma. Oncogene 2011, 30:4874-4886. 10.1038/onc.2011.195, 3165099, 21625222.
21. Park KS, Martelotto LG, Peifer M, Sos ML, Karnezis AN, Mahjoub MR, Bernard K, Conklin JF, Szczepny A, Yuan J, et al. A crucial requirement for hedgehog signaling in small cell lung cancer. Nat Med 2011, 17:1504-1508. 10.1038/nm.2473, 3380617, 21983857.
22. Varnat F, Duquet A, Malerba M, Zbinden M, Mas C, Gervaz P, Ruiz i Altaba A. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med 2009, 1:338-351. 10.1002/emmm.200900039, 3378144, 20049737.
23. Bidet M, Tomico A, Martin P, Guizouarn H, Mollat P, Mus-Veteau I. The Hedgehog receptor patched functions in multidrug transport and chemotherapy resistance. Mol Cancer Res 2012, 10:1496-1508. 10.1158/1541-7786.MCR-11-0578, 22752092.
24. Luan FJ. Establishment of the multidrug-resistant cell line K562/A02 and its drug-resistant properties. Zhonghua Zhong Liu Za Zhi 1993, 15:101-103.
25. Zhang XH, Zhang FY, Ji XJ, Li ZY. [Vincristine-resistant human KB cell line and mechanism of multidrug resistance]. Yao Xue Xue Bao 1994, 29:246-251.
26. Tan W, Martin D, Gutkind JS. The Galpha13-Rho signaling axis is required for SDF-1-induced migration through CXCR4. J Biol Chem 2006, 281:39542-39549. 10.1074/jbc.M609062200, 17056591.
27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63. 10.1016/0022-1759(83)90303-4, 6606682.
28. Stanton BZ, Peng LF, Maloof N, Nakai K, Wang X, Duffner JL, Taveras KM, Hyman JM, Lee SW, Koehler AN, et al. A small molecule that binds hedgehog and blocks its signaling in human cells. Nat Chem Biol 2009, 5:154-156. 10.1038/nchembio.142, 2770933, 19151731.
29. Chen JK, Taipale J, Cooper MK, Beachy PA. Inhibition of hedgehog signaling by direct binding of cyclopamine to smoothened. Genes Dev 2002, 16:2743-2748. 10.1101/gad.1025302, 187469, 12414725.
30. Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA, Baylin SB. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003, 422:313-317. 10.1038/nature01493, 12629553.
31. Bokoch GM, Katada T, Northup JK, Hewlett EL, Gilman AG. Identification of the predominant substrate for ADP-ribosylation by islet activating protein. J Biol Chem 1983, 258:2072-2075.
32. Federman AD, Conklin BR, Schrader KA, Reed RR, Bourne HR. Hormonal stimulation of adenylyl cyclase through Gi-protein beta gamma subunits. Nature 1992, 356:159-161. 10.1038/356159a0, 1312225.
33. Chen JK, Taipale J, Young KE, Maiti T, Beachy PA. Small molecule modulation of smoothened activity. Proc Natl Acad Sci USA 2002, 99:14071-14076. 10.1073/pnas.182542899, 137838, 12391318.
34. Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, Bonifas JM, Lam CW, Hynes M, Goddard A, et al. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 1998, 391:90-92. 10.1038/34201, 9422511.
35. Gutkind JS. Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors. Sci STKE 2000, 2000:re1.
36. Bonny C, Oberson A, Negri S, Sauser C, Schorderet DF. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 2001, 50:77-82. 10.2337/diabetes.50.1.77, 11147798.
37. Stebbins JL, De SK, Machleidt T, Becattini B, Vazquez J, Kuntzen C, Chen LH, Cellitti JF, Riel-Mehan M, Emdadi A, et al. Identification of a new JNK inhibitor targeting the JNK-JIP interaction site. Proc Natl Acad Sci USA 2008, 105:16809-16813. 10.1073/pnas.0805677105, 2567907, 18922779.
38. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994, 76:1025-1037. 10.1016/0092-8674(94)90380-8, 8137421.
39. Lei K, Nimnual A, Zong WX, Kennedy NJ, Flavell RA, Thompson CB, Bar-Sagi D, Davis RJ. The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol 2002, 22:4929-4942. 10.1128/MCB.22.13.4929-4942.2002, 133923, 12052897.
40. Lauth M, Bergstrom A, Shimokawa T, Toftgard R. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci USA 2007, 104:8455-8460. 10.1073/pnas.0609699104, 1866313, 17494766.
41. Jiang J, Hui CC. Hedgehog signaling in development and cancer. Dev Cell 2008, 15:801-812. 10.1016/j.devcel.2008.11.010, 19081070.
42. Ayers KL, Therond PP. Evaluating Smoothened as a G-protein-coupled receptor for Hedgehog signalling. Trends Cell Biol 2010, 20:287-298. 10.1016/j.tcb.2010.02.002, 20207148.
43. Brennan D, Chen X, Cheng L, Mahoney M, Riobo NA. Noncanonical hedgehog signaling. Vitam Horm 2012, 88:55-72. 3513281, 22391299.
44. Amakye D, Jagani Z, Dorsch M. Unraveling the therapeutic potential of the Hedgehog pathway in cancer. Nat Med 2013, 19:1410-1422. 10.1038/nm.3389, 24202394.
45. Teglund S, Toftgard R. Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochim Biophys Acta 1805, 2010:181-208.
46. Tian H, Callahan CA, DuPree KJ, Darbonne WC, Ahn CP, Scales SJ, de Sauvage FJ. Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis. Proc Natl Acad Sci USA 2009, 106:4254-4259. 10.1073/pnas.0813203106, 2647977, 19246386.
47. Romer JT, Kimura H, Magdaleno S, Sasai K, Fuller C, Baines H, Connelly M, Stewart CF, Gould S, Rubin LL, Curran T. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. Cancer Cell 2004, 6:229-240. 10.1016/j.ccr.2004.08.019, 15380514.
48. Sasai K, Romer JT, Lee Y, Finkelstein D, Fuller C, McKinnon PJ, Curran T. Shh pathway activity is down-regulated in cultured medulloblastoma cells: implications for preclinical studies. Cancer Res 2006, 66:4215-4222. 10.1158/0008-5472.CAN-05-4505, 16618744.
49. Becher OJ, Hambardzumyan D, Fomchenko EI, Momota H, Mainwaring L, Bleau AM, Katz AM, Edgar M, Kenney AM, Cordon-Cardo C, et al. Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas. Cancer Res 2008, 68:2241-2249. 10.1158/0008-5472.CAN-07-6350, 18381430.
50. Tuson M, He M, Anderson KV. Protein kinase A acts at the basal body of the primary cilium to prevent Gli2 activation and ventralization of the mouse neural tube. Development 2011, 138:4921-4930. 10.1242/dev.070805, 3201661, 22007132.
51. Wang B, Fallon JF, Beachy PA. Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell 2000, 100:423-434. 10.1016/S0092-8674(00)80678-9, 10693759.
52. Riobo NA, Lu K, Ai X, Haines GM, Emerson CP. Phosphoinositide 3-kinase and Akt are essential for sonic hedgehog signaling. Proc Natl Acad Sci USA 2006, 103:4505-4510. 10.1073/pnas.0504337103, 1450201, 16537363.
53. Riobo NA, Haines GM, Emerson CP. Protein kinase C-delta and mitogen-activated protein/extracellular signal-regulated kinase-1 control GLI activation in hedgehog signaling. Cancer Res 2006, 66:839-845. 10.1158/0008-5472.CAN-05-2539, 16424016.
54. Atwood SX, Li M, Lee A, Tang JY, Oro AE. GLI activation by atypical protein kinase C iota/lambda regulates the growth of basal cell carcinomas. Nature 2013, 494:484-488. 10.1038/nature11889, 3761364, 23446420.
55. Wang Y, Ding Q, Yen CJ, Xia W, Izzo JG, Lang JY, Li CW, Hsu JL, Miller SA, Wang X, et al. The crosstalk of mTOR/S6K1 and hedgehog pathways. Cancer Cell 2012, 21:374-387. 10.1016/j.ccr.2011.12.028, 3350095, 22439934.
56. Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009, 9:537-549. 10.1038/nrc2694, 19629069.
57. Vasilevskaya I, O'Dwyer PJ. Role of Jun and Jun kinase in resistance of cancer cells to therapy. Drug Resist Updat 2003, 6:147-156. 10.1016/S1368-7646(03)00043-8, 12860462.
58. Huang P, Han J, Hui L. MAPK signaling in inflammation-associated cancer development. Protein Cell 2010, 1:218-226. 10.1007/s13238-010-0019-9, 21203968.
59. Shaulian E. AP-1-the Jun proteins: oncogenes or tumor suppressors in disguise?. Cell Signal 2010, 22:894-899. 10.1016/j.cellsig.2009.12.008, 20060892.
60. Dijkgraaf GJ, Alicke B, Weinmann L, Januario T, West K, Modrusan Z, Burdick D, Goldsmith R, Robarge K, Sutherlin D, et al. Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance. Cancer Res 2011, 71:435-444. 10.1158/0008-5472.CAN-10-2876, 21123452.